Abdul Abdellatif

522 total citations
31 papers, 356 citations indexed

About

Abdul Abdellatif is a scholar working on Nephrology, Rheumatology and Surgery. According to data from OpenAlex, Abdul Abdellatif has authored 31 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 10 papers in Rheumatology and 8 papers in Surgery. Recurrent topics in Abdul Abdellatif's work include Gout, Hyperuricemia, Uric Acid (7 papers), Systemic Lupus Erythematosus Research (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Abdul Abdellatif is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (7 papers), Systemic Lupus Erythematosus Research (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Abdul Abdellatif collaborates with scholars based in United States. Abdul Abdellatif's co-authors include Samir J. Patel, A. Osama Gaber, Biruh Workeneh, Zaher Fanari, Waqar Haque, Wadi N. Suki, Katafan Achkar, Waqar Haque, Omar Pacha and Rajeev Raghavan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Abdul Abdellatif

31 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdul Abdellatif United States 13 133 82 78 61 52 31 356
Julien Aniort France 10 164 1.2× 84 1.0× 20 0.3× 23 0.4× 61 1.2× 36 379
Naohiro Wada Japan 12 252 1.9× 49 0.6× 30 0.4× 49 0.8× 51 1.0× 36 463
Nattawat Klomjit United States 11 227 1.7× 113 1.4× 24 0.3× 55 0.9× 94 1.8× 31 461
C. Baston Romania 12 51 0.4× 76 0.9× 26 0.3× 21 0.3× 72 1.4× 35 277
Agnieszka Prytula-Ebels Belgium 10 167 1.3× 75 0.9× 20 0.3× 103 1.7× 37 0.7× 33 361
O Otsubo Japan 14 174 1.3× 108 1.3× 23 0.3× 34 0.6× 40 0.8× 38 512
K.-H. Shu Taiwan 12 144 1.1× 149 1.8× 20 0.3× 26 0.4× 87 1.7× 38 493
Yudo Tanno Japan 12 232 1.7× 117 1.4× 13 0.2× 40 0.7× 68 1.3× 65 399
Scott J. Schurman United States 13 58 0.4× 109 1.3× 44 0.6× 100 1.6× 159 3.1× 26 530
H. Hedri Tunisia 11 78 0.6× 108 1.3× 52 0.7× 9 0.1× 55 1.1× 60 345

Countries citing papers authored by Abdul Abdellatif

Since Specialization
Citations

This map shows the geographic impact of Abdul Abdellatif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Abdellatif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Abdellatif more than expected).

Fields of papers citing papers by Abdul Abdellatif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdul Abdellatif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Abdellatif. The network helps show where Abdul Abdellatif may publish in the future.

Co-authorship network of co-authors of Abdul Abdellatif

This figure shows the co-authorship network connecting the top 25 collaborators of Abdul Abdellatif. A scholar is included among the top collaborators of Abdul Abdellatif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdul Abdellatif. Abdul Abdellatif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Johnson, Richard J., Brian F. Mandell, Naomi Schlesinger, et al.. (2024). Controversies and practical management of patients with gout and chronic kidney disease. Kidney International. 106(4). 573–582. 23 indexed citations
3.
Abdellatif, Abdul, et al.. (2023). Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open‐label PROTECT clinical trial. Clinical Transplantation. 37(9). e14993–e14993. 5 indexed citations
4.
Abdellatif, Abdul, et al.. (2022). eGFR Changes in Uncontrolled Gout Patients Randomized to Receive Methotrexate or Placebo as Co-Therapy to Pegloticase: MIRROR RCT Findings. Journal of the American Society of Nephrology. 33(11S). 851–851. 1 indexed citations
5.
Baraf, Herbert S. B., Robert T. Keenan, Christianne Yung, et al.. (2022). Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response. Current Rheumatology Reports. 24(1). 12–19. 8 indexed citations
6.
Fanari, Zaher, et al.. (2015). Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome: Still a myth or a fact that needs exploration?. Journal of the Saudi Heart Association. 27(4). 264–271. 29 indexed citations
7.
Dhingra, Sadhna, et al.. (2014). Tubulointerstitial nephritis in systemic lupus erythematosus: innocent bystander or ominous presage.. PubMed. 29(5). 553–65. 17 indexed citations
8.
Abdellatif, Abdul, et al.. (2014). Sodium hypochlorite-induced acute kidney injury. Saudi Journal of Kidney Diseases and Transplantation. 25(2). 381–381. 9 indexed citations
9.
Patel, Samir J., J. DeVos, Richard J. Knight, et al.. (2013). Effects of Rituximab on the Development of Viral and Fungal Infections in Renal Transplant Recipients. 2013. 1–8. 9 indexed citations
10.
Haque, Waqar, et al.. (2012). Rituximab in the treatment of refractory lupus nephritis with vasculitis.. SHILAP Revista de lepidopterología. 23(2). 334–7. 2 indexed citations
11.
12.
Workeneh, Biruh, et al.. (2011). Spectrum of sodium hypochlorite toxicity in man--also a concern for nephrologists. Clinical Kidney Journal. 4(4). 231–235. 34 indexed citations
13.
Patel, Samir J., Richard J. Knight, Abdul Abdellatif, et al.. (2011). The role of mTOR inhibition in renal transplant immune suppression. Dialysis & Transplantation. 40(1). 23–29. 5 indexed citations
14.
Gupta, Amit, et al.. (2011). Retroperitoneal sarcoma presenting as acute renal failure, secondary to bilateral renal artery invasion. Clinical Nephrology. 78(8). 164–168. 2 indexed citations
15.
Patel, Samir J., Richard J. Knight, Wadi N. Suki, et al.. (2011). Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age. Clinical Transplantation. 25(3). E250–6. 20 indexed citations
16.
Fanari, Zaher, et al.. (2010). Medical Management of Primary Hyperparathyroidism with Concommitant Multiple Myeloma. Internal Medicine. 49(6). 581–584. 10 indexed citations
17.
Paolini, Michael A., Katafan Achkar, Wadi N. Suki, et al.. (2010). Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus. Nephrology Dialysis Transplantation. 25(8). 2795–2798. 17 indexed citations
18.
Raghavan, Rajeev, et al.. (2010). Bortezomib in Kidney Transplantation. SHILAP Revista de lepidopterología. 2010. 1–6. 20 indexed citations
19.
Haque, Waqar, et al.. (2009). Catastrophic antiphospholipid syndrome presenting as ischemic pancreatitis in systemic lupus erythematosus.. PubMed. 10(5). 566–9. 5 indexed citations
20.
Haque, Waqar, et al.. (2009). Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy. Rheumatology International. 30(6). 719–723. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julien Aniort Breakdown of academic impact, for papers by Naohiro Wada Breakdown of academic impact, for papers by Nattawat Klomjit Breakdown of academic impact, for papers by C. Baston Breakdown of academic impact, for papers by Agnieszka Prytula-Ebels Breakdown of academic impact, for papers by O Otsubo Breakdown of academic impact, for papers by K.-H. Shu Breakdown of academic impact, for papers by Yudo Tanno Breakdown of academic impact, for papers by Scott J. Schurman Breakdown of academic impact, for papers by H. Hedri
Rankless by CCL
2026